DE69227689D1 - Verfahren zur herstellung von (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl] brombenzol - Google Patents

Verfahren zur herstellung von (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl] brombenzol

Info

Publication number
DE69227689D1
DE69227689D1 DE69227689T DE69227689T DE69227689D1 DE 69227689 D1 DE69227689 D1 DE 69227689D1 DE 69227689 T DE69227689 T DE 69227689T DE 69227689 T DE69227689 T DE 69227689T DE 69227689 D1 DE69227689 D1 DE 69227689D1
Authority
DE
Germany
Prior art keywords
brombenzol
oxazolyl
hydroxypropyl
phenyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69227689T
Other languages
English (en)
Other versions
DE69227689T2 (de
Inventor
George Quallich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69227689D1 publication Critical patent/DE69227689D1/de
Publication of DE69227689T2 publication Critical patent/DE69227689T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69227689T 1991-07-22 1992-07-01 Verfahren zur herstellung von (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl] brombenzol Expired - Fee Related DE69227689T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73356491A 1991-07-22 1991-07-22
PCT/US1992/005433 WO1993002060A1 (en) 1991-07-22 1992-07-01 Process for the preparation of intermediates in the synthesis of chiral thiazolidine-2,4-dione derivatives

Publications (2)

Publication Number Publication Date
DE69227689D1 true DE69227689D1 (de) 1999-01-07
DE69227689T2 DE69227689T2 (de) 1999-04-22

Family

ID=24948157

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227689T Expired - Fee Related DE69227689T2 (de) 1991-07-22 1992-07-01 Verfahren zur herstellung von (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl] brombenzol

Country Status (21)

Country Link
US (1) US5512689A (de)
EP (1) EP0595868B1 (de)
JP (1) JP2671962B2 (de)
AT (1) ATE173728T1 (de)
AU (1) AU660701B2 (de)
CA (1) CA2111445C (de)
DE (1) DE69227689T2 (de)
DK (1) DK0595868T3 (de)
ES (1) ES2123562T3 (de)
FI (1) FI940306A0 (de)
HU (1) HUT70412A (de)
IE (1) IE922359A1 (de)
IL (1) IL102574A (de)
MX (1) MX9204278A (de)
MY (1) MY131277A (de)
NO (1) NO940227L (de)
NZ (1) NZ243651A (de)
PT (1) PT100710B (de)
TW (1) TW199891B (de)
WO (1) WO1993002060A1 (de)
ZA (1) ZA925469B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU660187B2 (en) * 1991-07-22 1995-06-15 Pfizer Inc. Chiral intermediates for the preparation of antidiabetics thiazoles
FR2699172B1 (fr) * 1992-12-11 1995-01-20 Adir Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
TW416958B (en) * 1993-05-14 2001-01-01 Pfizer Enantioselective oxazaborolidine catalysts
CA2383347A1 (en) * 1999-08-31 2001-03-08 Maxia Pharmaceuticals, Inc. Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
IL157740A0 (en) 2001-03-07 2004-03-28 Incyte San Diego Inc Heterocyclic derivatives and pharmaceutical compositions containing the same
US7265139B2 (en) * 2001-03-08 2007-09-04 Incyte San Diego Inc. RXR activating molecules
CA2340824A1 (en) * 2001-03-14 2002-09-14 Ibm Canada Limited-Ibm Canada Limitee Method and system for application behavior analysis
EP1421061A4 (de) * 2001-08-17 2004-12-22 Incyte San Diego Inc Oximderivate für die behandlung von dyslipidämie und hypercholesterinämie
AU2002352706A1 (en) * 2001-11-15 2003-06-10 Maxia Pharmaceuticals, Inc. N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
US7196108B2 (en) * 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
WO2004066952A2 (en) * 2003-01-29 2004-08-12 Incyte Corporation Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
EP1643993A2 (de) * 2003-04-18 2006-04-12 Incyte San Diego Incorporated Substituiert isochroman-verbindungen zur behandlung von stoffwechselerkrankungen, krebs und anderen erkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943635A (en) * 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
TW222626B (de) * 1991-07-22 1994-04-21 Pfizer

Also Published As

Publication number Publication date
HUT70412A (en) 1995-10-30
CA2111445A1 (en) 1993-02-04
DE69227689T2 (de) 1999-04-22
EP0595868B1 (de) 1998-11-25
CA2111445C (en) 1997-02-18
TW199891B (de) 1993-02-11
FI940306A (fi) 1994-01-21
JP2671962B2 (ja) 1997-11-05
PT100710B (pt) 1999-07-30
AU2306292A (en) 1993-02-23
PT100710A (pt) 1993-09-30
NO940227D0 (no) 1994-01-21
IL102574A (en) 1996-07-23
HU9400188D0 (en) 1994-05-30
ATE173728T1 (de) 1998-12-15
MX9204278A (es) 1994-03-31
JPH07502017A (ja) 1995-03-02
DK0595868T3 (da) 1999-08-09
MY131277A (en) 2007-07-31
ZA925469B (en) 1994-01-21
IE922359A1 (en) 1993-01-27
US5512689A (en) 1996-04-30
NZ243651A (en) 1994-01-26
AU660701B2 (en) 1995-07-06
NO940227L (no) 1994-01-21
FI940306A0 (fi) 1994-01-21
ES2123562T3 (es) 1999-01-16
IL102574A0 (en) 1993-01-14
WO1993002060A1 (en) 1993-02-04
EP0595868A1 (de) 1994-05-11

Similar Documents

Publication Publication Date Title
DE69227689T2 (de) Verfahren zur herstellung von (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl] brombenzol
AT376424B (de) Verfahren zur herstellung von neuen 5-substituierten oxazolidin-2,4-dionen
DE69434023D1 (de) Verfahren zur effizienten Herstellung von 7-ADCA via 2-(carboxyethylthio)acetyl-7-ADCA und 3-(carboxymethylthio)propionyl-7-ADCA
ATE218131T1 (de) Verfahren zur herstellung von mono-n- substituierten tetraazamakrocyclen
DE68908582T2 (de) Verfahren zur Herstellung eines keramischen Vorformlings.
DE69500313T2 (de) Neues verfahren zur herstellung von clonidin-derivaten
DE69106233T2 (de) Verfahren zur Herstellung von gesintertem Siliciumnitridmaterial.
DE3588014D1 (de) Verfahren zur herstellung bissilylierter 3-iodmethylcephalosporinderivaten.
ATE238261T1 (de) Verfahren zur herstellung von orthoestern
DE69223765T2 (de) Verfahren zur Herstellung eines keramischen Spiegels.
ATE175408T1 (de) Verfahren zur herstellung von trans-(5r)-2,4,5- trisubstituierten 2-oxazolinen
ATE180481T1 (de) Verfahren zur herstellung von (-)-trans-n-p- fluorbenzoylmethyl-4-(p-fluorphenyl)-3-((3,4- (methylendioxy)phenoxy>methyl>-piperidin
ATE126208T1 (de) Verfahren zur herstellung von alpha- ((dialkylamino)substituiertes-methylen)-beta-ox - (substituiertes)-propannitrile.
ATE196632T1 (de) Verfahren zur herstellung von cephalosporinen
ATE193284T1 (de) Verfahren zur herstellung von benzylsubstituierten rhodaninederivaten
ATE222245T1 (de) Verfahren zur herstellung von benzyl- substituierten rhodanin derivaten
DE59108700D1 (de) Verfahren zur herstellung von 17-oxosteroiden
DE3575922D1 (de) Verfahren zur herstellung von 3,5-disubstituierten isoxazolen.
DE3878451T2 (de) Verfahren zur herstellung supraleitender keramischer materialien.
DE58907537D1 (de) Verfahren zur Herstellung eines Pyrrol-Derivats.
ATE7500T1 (de) Verfahren zur herstellung neuer sauerstoffhaltiger heterocyclen.
ATA431583A (de) Verfahren zur herstellung von neuen 5-substituierten oxazolidin-2,4-dionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee